Angela Cenci

Basal Ganglia Pathophysiology Unit, Experimental Medical Science, Lund University 
Parkinson's disease, L-DOPA induced dyskinesia
"Angela Cenci"
Mean distance: 15.17 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Francardo V, Geva M, Bez F, et al. (2019) Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Fieblinger T, Zanetti L, Sebastianutto I, et al. (2018) Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068
Sebastianutto I, Cenci MA. (2018) mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia. Current Opinion in Pharmacology. 38: 81-89
Francardo V, Schmitz Y, Sulzer D, et al. (2017) Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease. Experimental Neurology
Bimpisidis Z, M Öberg C, Maslava N, et al. (2017) Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease. Experimental Neurology
Alcacer C, Andreoli L, Sebastianutto I, et al. (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy. The Journal of Clinical Investigation
Sebastianutto I, Maslava N, Hopkins CR, et al. (2016) Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists. Neurobiology of Disease
Bez F, Francardo V, Cenci MA. (2016) Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion. Neurobiology of Disease
Marongiu R, Arango-Lievano M, Francardo V, et al. (2016) Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America
Carta M, Cenci MA. (2016) On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 149
See more...